The in vitro efficacy of mono‐EGF‐IT and bi‐EGF‐IT against HNSCC cell lines was assessed using the CellTiter‐Glo® Luminescent Cell Viability Assay. Here, EGF is linked to head and neck squamous cell carcinoma.